Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
4
PRCT Quote, Financials, Valuation and Earnings
Last price:
$28.14
Seasonality move
:
17.16%
Day range:
$27.56 - $28.86
52-week range:
$26.66 - $70.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.09x
P/B ratio:
4.08x
Volume:
887.6K
Avg. volume:
1.1M
1-year change:
-59.88%
Market cap:
$1.6B
Revenue:
$224.5M
EPS (TTM):
-$1.54
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PRCT
PROCEPT BioRobotics Corp.
|
$93.7M | -$0.32 | 37.32% | -7.78% | $50.73 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
ARAY
Accuray, Inc.
|
$100.9M | -$0.11 | -1.19% | -296.83% | $2.53 |
|
ATEC
Alphatec Holdings, Inc.
|
$212.3M | $0.04 | 20.01% | -91.85% | $24.62 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.32% | 75.74% | $104.78 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PRCT
PROCEPT BioRobotics Corp.
|
$27.79 | $50.73 | $1.6B | -- | $0.00 | 0% | 5.09x |
|
ABT
Abbott Laboratories
|
$112.68 | $133.39 | $195.9B | 30.43x | $0.63 | 2.13% | 4.44x |
|
ARAY
Accuray, Inc.
|
$0.55 | $2.53 | $62.1M | 149.00x | $0.00 | 0% | 0.14x |
|
ATEC
Alphatec Holdings, Inc.
|
$13.36 | $24.62 | $2B | -- | $0.00 | 0% | 2.72x |
|
BSX
Boston Scientific Corp.
|
$74.73 | $104.78 | $110.8B | 38.54x | $0.00 | 0% | 5.56x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.28 | $5.50 | $37.8M | -- | $0.00 | 0% | 4.41x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PRCT
PROCEPT BioRobotics Corp.
|
17.19% | 0.862 | 3.96% | 7.07x |
|
ABT
Abbott Laboratories
|
20.25% | 0.141 | -- | 1.12x |
|
ARAY
Accuray, Inc.
|
76.53% | 1.394 | 186.42% | 0.52x |
|
ATEC
Alphatec Holdings, Inc.
|
94.39% | 1.400 | 27.26% | 1.21x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.200 | -- | 0.81x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -1.387 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PRCT
PROCEPT BioRobotics Corp.
|
$52.4M | -$23.2M | -19.24% | -23.51% | -27.83% | -$9.5M |
|
ABT
Abbott Laboratories
|
$6.5B | $2.4B | 10.2% | 29.06% | 20.59% | $2.3B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | $8.4M |
|
ATEC
Alphatec Holdings, Inc.
|
$118.1M | -$9.4M | -25.96% | -1495.13% | -4.79% | $3.1M |
|
BSX
Boston Scientific Corp.
|
$3.7B | $1B | 8.4% | 12.46% | 19.69% | $1.2B |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
PROCEPT BioRobotics Corp. vs. Competitors
-
Which has Higher Returns PRCT or ABT?
Abbott Laboratories has a net margin of -25.7% compared to PROCEPT BioRobotics Corp.'s net margin of 15.5%. PROCEPT BioRobotics Corp.'s return on equity of -23.51% beat Abbott Laboratories's return on equity of 29.06%.
Company Gross Margin Earnings Per Share Invested Capital PRCTPROCEPT BioRobotics Corp.62.87% -$0.38 $459.2M ABTAbbott Laboratories57.09% $1.02 $64.2B -
What do Analysts Say About PRCT or ABT?
PROCEPT BioRobotics Corp. has a consensus price target of $50.73, signalling upside risk potential of 82.54%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 18.38%. Given that PROCEPT BioRobotics Corp. has higher upside potential than Abbott Laboratories, analysts believe PROCEPT BioRobotics Corp. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings PRCTPROCEPT BioRobotics Corp.8 3 0 ABTAbbott Laboratories16 7 0 -
Is PRCT or ABT More Risky?
PROCEPT BioRobotics Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.138%.
-
Which is a Better Dividend Stock PRCT or ABT?
PROCEPT BioRobotics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.13% to investors and pays a quarterly dividend of $0.63 per share. PROCEPT BioRobotics Corp. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.34% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRCT or ABT?
PROCEPT BioRobotics Corp. quarterly revenues are $83.3M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. PROCEPT BioRobotics Corp.'s net income of -$21.4M is lower than Abbott Laboratories's net income of $1.8B. Notably, PROCEPT BioRobotics Corp.'s price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 30.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PROCEPT BioRobotics Corp. is 5.09x versus 4.44x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRCTPROCEPT BioRobotics Corp.5.09x -- $83.3M -$21.4M ABTAbbott Laboratories4.44x 30.43x $11.5B $1.8B
-
Which has Higher Returns PRCT or ARAY?
Accuray, Inc. has a net margin of -25.7% compared to PROCEPT BioRobotics Corp.'s net margin of -13.47%. PROCEPT BioRobotics Corp.'s return on equity of -23.51% beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital PRCTPROCEPT BioRobotics Corp.62.87% -$0.38 $459.2M ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About PRCT or ARAY?
PROCEPT BioRobotics Corp. has a consensus price target of $50.73, signalling upside risk potential of 82.54%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 361.1%. Given that Accuray, Inc. has higher upside potential than PROCEPT BioRobotics Corp., analysts believe Accuray, Inc. is more attractive than PROCEPT BioRobotics Corp..
Company Buy Ratings Hold Ratings Sell Ratings PRCTPROCEPT BioRobotics Corp.8 3 0 ARAYAccuray, Inc.2 0 0 -
Is PRCT or ARAY More Risky?
PROCEPT BioRobotics Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.151, suggesting its more volatile than the S&P 500 by 15.124%.
-
Which is a Better Dividend Stock PRCT or ARAY?
PROCEPT BioRobotics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PROCEPT BioRobotics Corp. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRCT or ARAY?
PROCEPT BioRobotics Corp. quarterly revenues are $83.3M, which are smaller than Accuray, Inc. quarterly revenues of $102.2M. PROCEPT BioRobotics Corp.'s net income of -$21.4M is lower than Accuray, Inc.'s net income of -$13.8M. Notably, PROCEPT BioRobotics Corp.'s price-to-earnings ratio is -- while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PROCEPT BioRobotics Corp. is 5.09x versus 0.14x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRCTPROCEPT BioRobotics Corp.5.09x -- $83.3M -$21.4M ARAYAccuray, Inc.0.14x 149.00x $102.2M -$13.8M
-
Which has Higher Returns PRCT or ATEC?
Alphatec Holdings, Inc. has a net margin of -25.7% compared to PROCEPT BioRobotics Corp.'s net margin of -14.54%. PROCEPT BioRobotics Corp.'s return on equity of -23.51% beat Alphatec Holdings, Inc.'s return on equity of -1495.13%.
Company Gross Margin Earnings Per Share Invested Capital PRCTPROCEPT BioRobotics Corp.62.87% -$0.38 $459.2M ATECAlphatec Holdings, Inc.60.12% -$0.19 $626.3M -
What do Analysts Say About PRCT or ATEC?
PROCEPT BioRobotics Corp. has a consensus price target of $50.73, signalling upside risk potential of 82.54%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.62 which suggests that it could grow by 84.25%. Given that Alphatec Holdings, Inc. has higher upside potential than PROCEPT BioRobotics Corp., analysts believe Alphatec Holdings, Inc. is more attractive than PROCEPT BioRobotics Corp..
Company Buy Ratings Hold Ratings Sell Ratings PRCTPROCEPT BioRobotics Corp.8 3 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is PRCT or ATEC More Risky?
PROCEPT BioRobotics Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.013, suggesting its more volatile than the S&P 500 by 1.34%.
-
Which is a Better Dividend Stock PRCT or ATEC?
PROCEPT BioRobotics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PROCEPT BioRobotics Corp. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRCT or ATEC?
PROCEPT BioRobotics Corp. quarterly revenues are $83.3M, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $196.5M. PROCEPT BioRobotics Corp.'s net income of -$21.4M is higher than Alphatec Holdings, Inc.'s net income of -$28.6M. Notably, PROCEPT BioRobotics Corp.'s price-to-earnings ratio is -- while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PROCEPT BioRobotics Corp. is 5.09x versus 2.72x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRCTPROCEPT BioRobotics Corp.5.09x -- $83.3M -$21.4M ATECAlphatec Holdings, Inc.2.72x -- $196.5M -$28.6M
-
Which has Higher Returns PRCT or BSX?
Boston Scientific Corp. has a net margin of -25.7% compared to PROCEPT BioRobotics Corp.'s net margin of 12.68%. PROCEPT BioRobotics Corp.'s return on equity of -23.51% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital PRCTPROCEPT BioRobotics Corp.62.87% -$0.38 $459.2M BSXBoston Scientific Corp.69.58% $0.45 $35.7B -
What do Analysts Say About PRCT or BSX?
PROCEPT BioRobotics Corp. has a consensus price target of $50.73, signalling upside risk potential of 82.54%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.78 which suggests that it could grow by 42.89%. Given that PROCEPT BioRobotics Corp. has higher upside potential than Boston Scientific Corp., analysts believe PROCEPT BioRobotics Corp. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings PRCTPROCEPT BioRobotics Corp.8 3 0 BSXBoston Scientific Corp.25 0 0 -
Is PRCT or BSX More Risky?
PROCEPT BioRobotics Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.
-
Which is a Better Dividend Stock PRCT or BSX?
PROCEPT BioRobotics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PROCEPT BioRobotics Corp. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRCT or BSX?
PROCEPT BioRobotics Corp. quarterly revenues are $83.3M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. PROCEPT BioRobotics Corp.'s net income of -$21.4M is lower than Boston Scientific Corp.'s net income of $670M. Notably, PROCEPT BioRobotics Corp.'s price-to-earnings ratio is -- while Boston Scientific Corp.'s PE ratio is 38.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PROCEPT BioRobotics Corp. is 5.09x versus 5.56x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRCTPROCEPT BioRobotics Corp.5.09x -- $83.3M -$21.4M BSXBoston Scientific Corp.5.56x 38.54x $5.3B $670M
-
Which has Higher Returns PRCT or PSTV?
Plus Therapeutics, Inc. has a net margin of -25.7% compared to PROCEPT BioRobotics Corp.'s net margin of -316.61%. PROCEPT BioRobotics Corp.'s return on equity of -23.51% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PRCTPROCEPT BioRobotics Corp.62.87% -$0.38 $459.2M PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About PRCT or PSTV?
PROCEPT BioRobotics Corp. has a consensus price target of $50.73, signalling upside risk potential of 82.54%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1898.55%. Given that Plus Therapeutics, Inc. has higher upside potential than PROCEPT BioRobotics Corp., analysts believe Plus Therapeutics, Inc. is more attractive than PROCEPT BioRobotics Corp..
Company Buy Ratings Hold Ratings Sell Ratings PRCTPROCEPT BioRobotics Corp.8 3 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is PRCT or PSTV More Risky?
PROCEPT BioRobotics Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.886, suggesting its less volatile than the S&P 500 by 11.364%.
-
Which is a Better Dividend Stock PRCT or PSTV?
PROCEPT BioRobotics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PROCEPT BioRobotics Corp. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRCT or PSTV?
PROCEPT BioRobotics Corp. quarterly revenues are $83.3M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. PROCEPT BioRobotics Corp.'s net income of -$21.4M is lower than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, PROCEPT BioRobotics Corp.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PROCEPT BioRobotics Corp. is 5.09x versus 4.41x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRCTPROCEPT BioRobotics Corp.5.09x -- $83.3M -$21.4M PSTVPlus Therapeutics, Inc.4.41x -- $1.4M -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 17
Cooper-Standard Holdings, Inc. [CPS] is down 3.36% over the past day.
Buy
58
TPH alert for Feb 17
Tri Pointe Homes, Inc. [TPH] is down 0.24% over the past day.
Sell
20
IRON alert for Feb 17
Disc Medicine, Inc. [IRON] is up 17.19% over the past day.
